Literature DB >> 16766665

Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm.

A J Wyrobek1, B Eskenazi, S Young, N Arnheim, I Tiemann-Boege, E W Jabs, R L Glaser, F S Pearson, D Evenson.   

Abstract

This study compares the relative effects of advancing male age on multiple genomic defects in human sperm [DNA fragmentation index (DFI), chromatin integrity, gene mutations, and numerical chromosomal abnormalities], characterizes the relationships among these defects and with semen quality, and estimates the incidence of susceptible individuals for a well characterized nonclinical nonsmoking group of 97 men (22-80 years). Adjusting for confounders, we found major associations between age and the frequencies of sperm with DFI and fibroblast growth factor receptor 3 gene (FGFR3) mutations associated with achondroplasia (P < 0.01) with no evidence for age thresholds. However, we found no associations between age and the frequencies of sperm with immature chromatin, aneuploidies/diploidies, FGFR2 mutations (Apert syndrome), or sex ratio in this cohort. There were also no consistent correlations among genomic and semen-quality endpoints, except between DFI and sperm motility (r = -0.65, P < 0.001). These findings suggest there are multiple spermatogenic targets for genomically defective sperm with substantially variable susceptibilities to age. Our findings predict that as healthy males age, they have decreased pregnancy success with trends beginning in their early reproductive years, increased risk for producing offspring with achondroplasia mutations, and risk of fathering offspring with Apert syndrome that may vary across cohorts, but with no increased risk for fathering aneuploid offspring (Down, Klinefelter, Turner, triple X, and XYY syndromes) or triploid embryos. Our findings also suggest that the burden of genomic damage in sperm cannot be inferred from semen quality, and that a small fraction of men are at increased risk for transmitting multiple genetic and chromosomal defects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766665      PMCID: PMC1480453          DOI: 10.1073/pnas.0506468103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Characteristics of human sperm chromatin structure following an episode of influenza and high fever: a case study.

Authors:  D P Evenson; L K Jost; M Corzett; R Balhorn
Journal:  J Androl       Date:  2000 Sep-Oct

Review 2.  Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies.

Authors:  Andrew J Wyrobek; Thomas E Schmid; Francesco Marchetti
Journal:  J Natl Cancer Inst Monogr       Date:  2005

3.  Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.

Authors:  D J Wilkin; J K Szabo; R Cameron; S Henderson; G A Bellus; M L Mack; I Kaitila; J Loughlin; A Munnich; B Sykes; J Bonaventure; C A Francomano
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

4.  Relationship between the outcomes of assisted reproductive techniques and sperm DNA fragmentation as measured by the sperm chromatin structure assay.

Authors:  Kjersten L Larson-Cook; John D Brannian; Keith A Hansen; Kay M Kasperson; Edward T Aamold; Donald P Evenson
Journal:  Fertil Steril       Date:  2003-10       Impact factor: 7.329

5.  Effects of age on DNA double-strand breaks and apoptosis in human sperm.

Authors:  Narendra P Singh; Charles H Muller; Richard E Berger
Journal:  Fertil Steril       Date:  2003-12       Impact factor: 7.329

6.  The influence of paternal age on down syndrome.

Authors:  Harry Fisch; Grace Hyun; Robert Golden; Terry W Hensle; Carl A Olsson; Gary L Liberson
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

7.  Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  Michael R Virro; Kjersten L Larson-Cook; Donald P Evenson
Journal:  Fertil Steril       Date:  2004-05       Impact factor: 7.329

8.  Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.

Authors:  Anne Goriely; Gilean A T McVean; Maria Röjmyr; Björn Ingemarsson; Andrew O M Wilkie
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

Review 9.  Role of reactive oxygen species in the pathophysiology of human reproduction.

Authors:  Ashok Agarwal; Ramadan A Saleh; Mohamed A Bedaiwy
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

10.  Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis.

Authors:  Stefan Aretz; Siegfried Uhlhaas; Reiner Caspari; Elisabeth Mangold; Constanze Pagenstecher; Peter Propping; Waltraut Friedl
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

View more
  100 in total

1.  Apoptotic sperm biomarkers and their correlation with conventional sperm parameters and male fertility potential.

Authors:  Branko Zorn; Barbara Golob; Alojz Ihan; Andreja Kopitar; Mojca Kolbezen
Journal:  J Assist Reprod Genet       Date:  2012-02-24       Impact factor: 3.412

2.  Paternal levels of DNA damage in spermatozoa and maternal parity influence offspring mortality in an endangered ungulate.

Authors:  María José Ruiz-López; Gerardo Espeso; Donald P Evenson; Eduardo R S Roldan; Montserrat Gomendio
Journal:  Proc Biol Sci       Date:  2010-04-14       Impact factor: 5.349

3.  One abstinence day decreases sperm DNA fragmentation in 90 % of selected patients.

Authors:  Isabel Pons; Rosa Cercas; Celia Villas; Cristina Braña; Sylvia Fernández-Shaw
Journal:  J Assist Reprod Genet       Date:  2013-09-01       Impact factor: 3.412

4.  The effects of male aging on semen quality, sperm DNA fragmentation and chromosomal abnormalities in an infertile population.

Authors:  Sonia Brahem; Meriem Mehdi; Hatem Elghezal; Ali Saad
Journal:  J Assist Reprod Genet       Date:  2011-02-03       Impact factor: 3.412

5.  Detection of DNA fragmentation and meiotic segregation in human with isolated teratozoospermia.

Authors:  Sonia Brahem; Meriem Mehdi; Hatem Elghezal; Ali Saad
Journal:  J Assist Reprod Genet       Date:  2010-09-25       Impact factor: 3.412

6.  Effects of men and recipients' age on the reproductive outcome of an oocyte donation program.

Authors:  Inmaculada Campos; Emilio Gómez; Ana Lucia Fernández-Valencia; José Landeras; Rafaela González; Pilar Coy; Joaquín Gadea
Journal:  J Assist Reprod Genet       Date:  2008-10-07       Impact factor: 3.412

7.  The effects of age on DNA fragmentation, chromatin packaging and conventional semen parameters in spermatozoa of oligoasthenoteratozoospermic patients.

Authors:  Konstantina Plastira; Pavlos Msaouel; Roxani Angelopoulou; Kyriaki Zanioti; Aris Plastiras; Alexios Pothos; Stamatis Bolaris; Nikolaos Paparisteidis; Dimitris Mantas
Journal:  J Assist Reprod Genet       Date:  2007-09-04       Impact factor: 3.412

8.  A parent-of-origin analysis of paternal genetic variants and increased risk of conotruncal heart defects.

Authors:  Wendy N Nembhard; Xinyu Tang; Jingyun Li; Stewart L MacLeod; Joseph Levy; Gerald B Schaefer; Charlotte A Hobbs
Journal:  Am J Med Genet A       Date:  2018-02-05       Impact factor: 2.802

9.  Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004.

Authors:  Ridgely Fisk Green; Owen Devine; Krista S Crider; Richard S Olney; Natalie Archer; Andrew F Olshan; Stuart K Shapira
Journal:  Ann Epidemiol       Date:  2010-01-06       Impact factor: 3.797

10.  Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience : prenatal diagnosis in FGFR3 gene.

Authors:  M J Trujillo-Tiebas; M Fenollar-Cortés; I Lorda-Sánchez; J Díaz-Recasens; A Carrillo Redondo; C Ramos-Corrales; C Ayuso
Journal:  J Assist Reprod Genet       Date:  2009-09-30       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.